Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

127.80
Delayed Data
As of May 27
 +5.17 / +4.22%
Today’s Change
63.68
Today|||52-Week Range
137.50
+7.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues138.4M179.0M144.6M138.5M
 
 
 
 
 
Cost of Goods Sold3.1M5.7M5.9M4.1M
 
 
 
 
 
Depreciation And Amortization14.2M17.0M16.3M16.4M
 
 
 
 
 
 
Operating ExpensesGross Income121.1M156.3M122.4M118.0M
 
 
 
 
 
General Expenses302.2M257.7M271.8M293.3M
 
 
 
 
 
Research And Development224.8M190.9M201.5M215.6M
 
 
 
 
 
Total Operating Expenses319.5M280.3M294.0M313.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-181.1M-101.4M-149.5M-175.3M
 
 
 
 
 
Extraordinary Credit270.0K0.00--3.3M
 
 
 
Extraordinary Charge---40.8M-33.2M0.00
 
 
 
Interest Expense On Debt15.6M20.4M21.2M21.3M
 
 
 
 
 
Other Expenses37.7M-4.0M25.2M-5.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-158.7M-166.6M-178.6M-198.4M
 
 
 
 
 
Income Taxes-693.0K-3.4M-2.0M-299.0K
 
 
 
 
 
Minority Interest0.000.00-4.2M-98.0K
 
 
 
Discontinued Operations0.00-64.0K-209.0K0.00
 
 
 
Net Income-159.4M-170.1M-176.7M-198.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS233.8M236.1M238.3M239.5M
 
 
 
 
 
Shares To Calculate EPS Diluted233.8M236.1M238.3M239.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.68-$0.72-$0.74-$0.83
 
 
 
 
 
EPS Diluted-$0.68-$0.72-$0.74-$0.83
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account